Xeris Biopharma Holdings, Inc. (XERS) Earnings Report - Discounting Cash Flows
XERS
Xeris Biopharma Holdings, Inc.
XERS (NASDAQ)
Period Ending: 2026
05-06
2026
03-02
2025
11-06
2025
08-07
2025
05-08
2025
03-06
2024
11-08
2024
08-08
2024
05-09
2024
03-06
2023
11-09
2023
08-08
2023
05-09
2023
03-08
2022
11-09
2022
08-10
2022
05-11
2022
03-10
2021
11-10
2021
08-05
2021
05-13
2021
03-09
2020
11-09
2020
08-10
2020
05-07
2020
03-11
2019
11-07
2019
08-06
2019
05-09
2019
03-06
2018
11-07
2018
08-13
2018
06-21
2018
03-30
2017
09-29
2017
06-29
2017
03-30
Actual EPS - - 0.00 -0.01 -0.06 -0.03 -0.06 -0.10 -0.14 -0.10 -0.09 -0.14 -0.12 -0.10 -0.14 -0.19 -0.25 -0.42 -0.36 -0.41 -0.30 -0.41 -0.35 -0.63 -0.89 -1.23 -1.22 -1.28 -1.07 -0.98 -0.71 -3.07 -4.43 -5.49 -3.72 -2.59 -2.29
Estimated EPS - 0.03 0.01 -0.03 -0.07 -0.08 -0.09 -0.11 -0.12 -0.09 -0.12 -0.13 -0.17 -0.16 -0.17 -0.23 -0.24 -0.21 -0.37 -0.31 -0.31 -0.39 -0.54 -0.71 -0.92 -1.24 -1.26 -0.97 -0.83 -1.04 -0.84 -0.88 - - - - -
Actual Revenue - - 74.38 71.54 60.12 60.1 54.27 48.06 40.64 44.39 48.32 38.01 33.2 33.14 29.73 25.31 22.07 21.43 11.04 8.91 8.05 7.09 9.45 2.03 1.79 1.86 0.323 0.32 0.248 0.801 0.582 0.819 0.467 0.263 0.17 0.565 0.354
Estimated Revenue - 86 86 72.25 57.61 54.9 51.43 45.81 41.81 45.81 42.7 35.16 31.03 30.96 29.04 41.08 23.39 18.97 11.01 8.91 9 - 12.54 2.35 1.79 1.68 0.326 0.235 0.176 0.76 0.639 1.1 - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program